We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Visual System Changes May Provide Biomarkers for PD

By HospiMedica International staff writers
Posted on 10 Jul 2017
Researchers have found that visual system changes may provide an early indication of Parkinson’s disease and help clinicians monitor the disease.

Such changes could become apparent ten years before the motor symptoms of the disease, and may include a change in visual acuity, an inability to perceive colors, and a decrease in the rate of blinking. More...
Visual symptoms may appear more than 10 years before motor symptoms.

The researchers from the University Vita-Salute San Raffaele (Milan, Italy) published the results of their research online in the July 11, 2017, issue of the journal Radiology. The study included 11 men and 9 women, all newly diagnosed, but not yet treated for Parkinson’s disease (PD), and age- and gender-matched healthy control group of 20 people. The research team included ophthalmology, neurology and neuroradiology specialists.

The researchers used a Magnetic Resonance Imaging (MRI) Diffusion Weighted Imaging (DWI) to scan both the patients and the healthy controls. The patients were scanned within four weeks of their diagnosis to assess changes in the grey and white matter concentration of the brain, as well as Voxel-Based Morphometry (VBM). All participants of the study also underwent ophthalmologic examinations.

The results indicated significant abnormalities in the visual system brain structures of the Parkinson’s disease patients including a reduction of white matter concentration, alterations of optic radiations, and less optic chiasm volume.

Lead researcher, Dr. Alessandro Arrigo, MD, a resident in ophthalmology, said, "Although Parkinson’s disease is primarily considered a motor disorder, several studies have shown non-motor symptoms are common across all stages of the disease. These non-motor Parkinson’s symptoms may precede the appearance of motor signs by more than a decade. The study in depth of visual symptoms may provide sensitive markers of Parkinson’s disease. Visual processing metrics may prove helpful in differentiating Parkinsonism disorders, following disease progression, and monitoring patient response to drug treatment."

Related Links:
University Vita-Salute San Raffaele


Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Immobilization System
Cranial 4Pi Immobilization
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.